ELLIPTIC LABORATORIES ASA (ELABS.OL) Stock Cash Flow
Europe - Euronext Oslo - OSL:ELABS - NO0010722283 - Common Stock
5.82 NOK
+0.13 (+2.28%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 445.00K | 17.05M | -46.86M | -39.30M | -13.09M | |||
| Depreciation Amortization | 24.75M | 21.86M | 16.22M | 11.32M | 8.31M | |||
| Change In Working Capital | -9.67M | -51.60M | -16.72M | 1.27M | -17.03M | |||
| Interest Paid | 1.48M | 1.83M | 1.95M | 1.24M | 653.00K | |||
| Other non cash items | 8.64M | 2.09M | 9.40M | 9.37M | 10.99M | |||
| OPERATING CASH FLOW | 24.17M | -10.61M | -38.10M | -17.34M | -10.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -28.70M | -30.50M | -25.61M | -23.33M | -17.61M | |||
| Other Investing Activity | 4.59M | 5.95M | 896.00K | 2.24M | N/A | |||
| INVESTING CASH FLOW | -24.11M | -24.55M | -24.72M | -21.09M | -17.61M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.82M | -10.14M | -9.01M | -7.21M | -6.23M | |||
| Stock Issued/Repurchased | 123.00K | 4.83M | 9.49M | 2.97M | 162.22M | |||
| Other Financing Activity | -1.48M | -1.83M | -1.95M | 1.97M | -9.19M | |||
| FINANCING CASH FLOW | -11.18M | -7.13M | -1.46M | -2.26M | 146.80M | |||
| Exchange Rate Effect | -1.20M | 3.10M | 1.64M | 760.00K | 59.00K | |||
| CHANGE IN CASH | -12.31M | -39.19M | -62.64M | -39.93M | 118.43M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 24.17M | -10.61M | -38.10M | -17.34M | -10.82M | |||
| Capital Expenditure | -28.70M | -30.50M | -25.61M | -23.33M | -17.61M | |||
| FREE CASH FLOW | -4.52M | -41.11M | -63.71M | -40.67M | -28.43M | |||
All data in NOK